Abstract
Background: Bowens disease is a form of squamous cell carcinoma in situ that can be transformed into invasive squamous cell carcinoma and should be treated according to its anatomical position. The aim of this article is to offer an overview of treatment options with an emphasis on radiation therapy in the treatment of Bowens disease. Methods and Materials: We performed overview of the literature based on database searches in PubMed/MEDLINE and we included articles till December 2010. Only papers published in English were included. Results: There was no standard fractionation regimen: some physicians prescribed high doses, such as the ones of invasive skin cancer, whereas others prescribed lower doses because of the noninvasive nature of the disease, the sensitive anatomic location (e.g., extremity) and the large treatment area. Various studies demonstrate high rates of tumor control with minimal morbidity following definitive radiation therapy in the treatment of Bowens Disease. Through a multidisciplinary assessment, the treatment of Bowens disease can be individualized to optimize patient care. Conclusions: Radiation therapy is an effective treatment option for Bowens disease of the skin. Local recurrences seem to be equally low in patients treated with high- and low-dose regimens. Radiotherapy preserves normal tissues ensuring a superior esthetic and functional outcome.
Keywords: Bowen's disease, toxicity, review, radiotherapy, cosmesis, Photodynamic therapy, Methyl aminolevulinate, non melanoma skin cancer, Cryotherapy, Surgical excision
Reviews on Recent Clinical Trials
Title: The Potential Role of Radiation Therapy in Bowens Disease: A Review of the Current Literature
Volume: 7 Issue: 1
Author(s): Zygogianni Anna, Kouvaris John, Tolia Maria, Kyrgias George, Beli Ivelina, Kantzou Ioanna, Soulimioti Georgia and Kouloulias Vassilis
Affiliation:
Keywords: Bowen's disease, toxicity, review, radiotherapy, cosmesis, Photodynamic therapy, Methyl aminolevulinate, non melanoma skin cancer, Cryotherapy, Surgical excision
Abstract: Background: Bowens disease is a form of squamous cell carcinoma in situ that can be transformed into invasive squamous cell carcinoma and should be treated according to its anatomical position. The aim of this article is to offer an overview of treatment options with an emphasis on radiation therapy in the treatment of Bowens disease. Methods and Materials: We performed overview of the literature based on database searches in PubMed/MEDLINE and we included articles till December 2010. Only papers published in English were included. Results: There was no standard fractionation regimen: some physicians prescribed high doses, such as the ones of invasive skin cancer, whereas others prescribed lower doses because of the noninvasive nature of the disease, the sensitive anatomic location (e.g., extremity) and the large treatment area. Various studies demonstrate high rates of tumor control with minimal morbidity following definitive radiation therapy in the treatment of Bowens Disease. Through a multidisciplinary assessment, the treatment of Bowens disease can be individualized to optimize patient care. Conclusions: Radiation therapy is an effective treatment option for Bowens disease of the skin. Local recurrences seem to be equally low in patients treated with high- and low-dose regimens. Radiotherapy preserves normal tissues ensuring a superior esthetic and functional outcome.
Export Options
About this article
Cite this article as:
Anna Zygogianni, John Kouvaris, Maria Tolia, George Kyrgias, Ivelina Beli, Ioanna Kantzou, Georgia Soulimioti and Vassilis Kouloulias, The Potential Role of Radiation Therapy in Bowens Disease: A Review of the Current Literature, Reviews on Recent Clinical Trials 2012; 7(1) . https://dx.doi.org/10.2174/157488712799363271
DOI https://dx.doi.org/10.2174/157488712799363271 |
Print ISSN 1574-8871 |
Publisher Name Bentham Science Publisher |
Online ISSN 1876-1038 |

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
The Role of DNA-Microarray in Translational Cancer Research
Current Pharmacogenomics Targeting MDM2-p53 Interaction for Cancer Therapy: Are We There Yet?
Current Medicinal Chemistry The Bioanalytical Molecular Pharmacology of the N-methyl-<sub>D</sub>-Aspartate (NMDA) Receptor Nexus and the Oxygen-Responsive Transcription Factor HIF-1α : Putative Mechanisms and Regulatory Pathways Unravel the Intimate Hypoxia Connection
Current Molecular Pharmacology Diverse Roles of GADD45α in Stress Signaling
Current Protein & Peptide Science New Molecular and Cellular Targets for Chemoprevention and Treatment of Skin Tumors by Plant Polyphenols: A Critical Review
Current Medicinal Chemistry Role of microRNAs in Gynecological Pathology
Current Medicinal Chemistry A Review on Multi-organ Cancer Detection Using Advanced Machine Learning Techniques
Current Medical Imaging KSP Inhibitors as Antimitotic Agents
Current Topics in Medicinal Chemistry Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: Current Status and Future Perspectives in the Development of Novel Irreversible Inhibitors for the Treatment of Mutant Non-small Cell Lung Cancer
Current Pharmaceutical Design The Role of NF-κB Inhibitors in Cell Response to Radiation
Current Medicinal Chemistry A Focus on Microfluidics and Nanotechnology Approaches for the Ultra Sensitive Detection of MicroRNA
MicroRNA Vascular Endothelial Growth Factor Receptor as Target for Advanced Non-Small Cell Lung Cancer Therapy
Current Drug Targets Metallic Nanoparticles: A New Frontier in the Fight Against Leishmaniasis
Current Medicinal Chemistry Transmembrane Protein 166 and its Significance
Protein & Peptide Letters Moving Beyond VEGF for Anti-angiogenesis Strategies in Gynecologic Cancer
Current Pharmaceutical Design Effective Treatment of Human Lung Cancer by Targeting Tissue Factor with a Factor VII-Targeted Photodynamic Therapy
Current Cancer Drug Targets Antiviral Medication in Sexually Transmitted Diseases. Part I: HSV, HPV
Mini-Reviews in Medicinal Chemistry Advances in Targeting Insulin-like Growth Factor Signaling Pathway in Cancer Treatment
Current Pharmaceutical Design Human Apurinic/Apyrimidinic Endonuclease (APE1): An Emerging Anti-Cancer Biomarker
Recent Patents on Biomarkers Cellular Strategies to Combat Protein Misfolding: Intricate Role of Hsp70 in Stress Management
Current Chemical Biology